Dosing
For the infant population two
weeks to one year of age, dosing is
dependent on weight; in older children,
the dose is standardized (see
Table 1) (FDA, 2012). The dosing in
infants is three milligrams per kilogram
per dose twice daily for five days
(FDA, 2012).This dose was extrapolated
based on data of safety and efficacy
of the adult and pediatric dosing.
In the pediatric population under 12
years of age, it has been shown thatclearance of the prodrug and its active
form slows as the child gets older
(Roche Laboratories Inc., 2008). This
accounts for the higher mg/kg dose
required for the younger population
(Roche Laboratories Inc., 2008). The
dosing syringe currently packaged
with oseltamivir phosphate is not calibrated
for these infant doses, and the
pharmacist should include a dispenser
to ensure accurate dosing and
prevent overdosing (FDA, 2012)
DosingFor the infant population twoweeks to one year of age, dosing isdependent on weight; in older children,the dose is standardized (seeTable 1) (FDA, 2012). The dosing ininfants is three milligrams per kilogramper dose twice daily for five days(FDA, 2012).This dose was extrapolatedbased on data of safety and efficacyof the adult and pediatric dosing.In the pediatric population under 12years of age, it has been shown thatclearance of the prodrug and its activeform slows as the child gets older(Roche Laboratories Inc., 2008). Thisaccounts for the higher mg/kg doserequired for the younger population(Roche Laboratories Inc., 2008). Thedosing syringe currently packagedwith oseltamivir phosphate is not calibratedfor these infant doses, and thepharmacist should include a dispenserto ensure accurate dosing andprevent overdosing (FDA, 2012)
การแปล กรุณารอสักครู่..
